Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 17/20 | 0.61 |
| ▸ | LOX | P28300 | 5/20 | 0.61 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.61 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.47 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | CCR8 | P51685 | 1/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7036361 | 0.88 | LOXL2 (0.56) | LOXL2LOXLOXL3CCR1CCR5 | |
| SCHEMBL30485802 | 0.88 | LOXL2 (0.56) | LOXL2LOXLOXL3CCR1CCR5 | |
| SCHEMBL29978828 | 0.88 | CCR1 (0.65) | LOXL2LOXLOXL3CCR1CCR5 | |
| SCHEMBL5991845 | 0.83 | LOXL2 (0.70) | LOXL2LOXLOXL3 | |
| SCHEMBL14303459 | 0.82 | LOXL2 (0.64) | LOXL2LOXLOXL3ROCK1ADRB2 | |
| SCHEMBL17923476 | 0.82 | LOXL2 (0.72) | LOXL2 | |
| SCHEMBL18233498 | 0.80 | LOXL2 (0.62) | LOXL2LOXLOXL3 | |
| SCHEMBL28505430 | 0.80 | LOXL2 (0.58) | LOXL2LOXLOXL3ROCK1ADRB2 | |
| SCHEMBL18049349 | 0.80 | LOXL2 (0.62) | LOXL2LOXLOXL3 | |
| SCHEMBL4107151 | 0.80 | LOXL2 (0.61) | LOXL2LOXLOXL3ROCK1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016071465-A1 | LUMINESCENT RUTHENIUM (II) COMPLEXES AND THEIR USE IN PH SENSORS | TAP BIOSYSTEMS (PHC) LIMITED (GB) | 2016-05-12 | — | — | WO | disclosed |
| US-8951400-B2 | Chemistry used in biosensors | OHMX CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| WO-2012012537-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | OHMX CORPORATION (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20120012472-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | OHMX CORPORATION (US) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120012472-A1 | NOVEL CHEMISTRY USED IN BIOSENSORS | SSBP1, OSGEP, OCIAD2 | LOXL2 2384/4885LOX 1498/4885LOXL3 2462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.